5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.07▲ | 3.06▲ | 3.05▲ | 2.69▲ | 2.17▲ |
MA10 | 3.05▲ | 3.04▲ | 2.95▲ | 2.36▲ | 1.71▲ |
MA20 | 3.03▲ | 2.86▲ | 2.65▲ | 2.06▲ | 1.24▲ |
MA50 | 2.88▲ | 2.56▲ | 2.38▲ | 1.58▲ | 0.85▲ |
MA100 | 2.62▲ | 2.30▲ | 2.10▲ | 1.16▲ | 1.01▲ |
MA200 | 2.42▲ | 2.00▲ | 1.75▲ | 0.86▲ | 8.04▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | 0.007▲ | 0.042▲ | 0.099▲ | 0.198▲ |
RSI | 61.900▲ | 70.956▲ | 74.726▲ | 75.975▲ | 85.346▲ |
STOCH | 74.747 | 80.566▲ | 93.481▲ | 82.003▲ | 82.993▲ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -0.725▲ | -0.419▲ |
CCI | 97.121 | 101.070▲ | 90.409 | 185.620▲ | 200.763▲ |
Thursday, June 26, 2025 05:16 AM
SILICON VALLEY, CA- June 26, 2025- ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS, and oncology/hematology, proudly ...
|
Friday, June 06, 2025 05:44 AM
ABVC's Oncology Licensing to OncoX Highlights Scalable Royalty Strategy. SILICON VALLEY, CA - June 6, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage ...
|
Wednesday, May 14, 2025 06:15 AM
According to Nasdaq's notification dated May 13, 2025, ABVC's common stock successfully maintained a closing bid price at or above $1.00 for 10 consecutive trading days from April 29, 2025 to May ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 3.08 | 3.12 | 2.80 | 3.11 | 662,074 |
02/07/25 | 2.44 | 3.10 | 2.38 | 3.10 | 1,171,515 |
01/07/25 | 2.27 | 2.45 | 2.27 | 2.42 | 493,979 |
30/06/25 | 2.65 | 2.70 | 2.16 | 2.225 | 953,812 |
27/06/25 | 2.23 | 2.60 | 2.20 | 2.59 | 809,240 |
26/06/25 | 2.15 | 2.25 | 2.14 | 2.19 | 292,490 |
25/06/25 | 2.12 | 2.29 | 2.12 | 2.12 | 370,303 |
24/06/25 | 1.98 | 2.065 | 1.96 | 2.06 | 187,566 |
23/06/25 | 1.85 | 2.0399 | 1.85 | 1.96 | 199,086 |
20/06/25 | 1.94 | 1.97 | 1.84 | 1.84 | 242,822 |
|
|
||||
|
|
||||
|
|